Treatment of<unk>  is for the most part palliative and limited to symptom management. Sometimes, the bone destruction spontaneously ceases and no treatment is required, but when the disease is progressive, aggressive intervention may be necessary. Duffy and colleagues reported that around 17% of people with<unk>  in the ribs, shoulder, or upper spine experience extension of the disease into the chest, leading to chylothorax with its serious consequences, and that the mortality rate in this group can reach as high as 64% without surgical intervention. A search of the medical literature reveals multiple case reports of interventions with varying rates of success as follows: Cardiothoracic (heart and lung): * Pleurodesis * Ligation of thoracic duct * Pleurperitoneal shunt * Radiation therapy * Pleurectomy * Surgical resection * Thalidomide * Interferon alpha-2b * TPN (total parenteral nutrition) * Thoracentesis * Diet rich in medium-chain triglycerides and protein * Chemotherapy * Sclerotherapy * Transplantation Skeletal: * Interferon alpha-2b * Bisphosphonate (e.g. pamidronate) * Surgical resection * Radiation therapy * Sclerotherapy * Percutaneous bone cement * Bone graft * Prosthesis * Surgical stabilization * Amputation To date, no known interventions are consistently effective for<unk> 's, and all reported interventions are considered experimental treatments, though many are routine for other conditions. Some people may require a combination of these approaches. Unfortunately, some people will not respond to any intervention.
Gorham's disease
Darier's disease
Chandler's disease
Texier's disease
Camisa disease
Milroy's disease
Minor's disease
Tornwaldt's disease